Biomark Diagnostics Inc. BUX.CN Stock
Biomark Diagnostics Inc. Price Chart
Biomark Diagnostics Inc. BUX.CN Financial and Trading Overview
| Biomark Diagnostics Inc. stock price | 0.24 CAD |
| Previous Close | 0.31 CAD |
| Open | 0 CAD |
| Bid | 0.31 CAD x 0 |
| Ask | 0.32 CAD x 0 |
| Day's Range | 0 - 0 CAD |
| 52 Week Range | 0 - 0.35 CAD |
| Volume | 0 CAD |
| Avg. Volume | 15.81K CAD |
| Market Cap | 25.4M CAD |
| Beta (5Y Monthly) | 0.347892 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BUX.CN Valuation Measures
| Enterprise Value | 26.95M CAD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 184.26018 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 195.464 |
| Enterprise Value/EBITDA | -13.121 |
Trading Information
Biomark Diagnostics Inc. Stock Price History
| Beta (5Y Monthly) | 0.347892 |
| 52-Week Change | 7.01% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.35 CAD |
| 52 Week Low | 0 CAD |
| 50-Day Moving Average | 0.27 CAD |
| 200-Day Moving Average | 0.22 CAD |
BUX.CN Share Statistics
| Avg. Volume (3 month) | 15.81K CAD |
| Avg. Daily Volume (10-Days) | 10.08K CAD |
| Shares Outstanding | 83.29M |
| Float | 32.74M |
| Short Ratio | 0.02 |
| % Held by Insiders | 54.77% |
| % Held by Institutions | 0% |
| Shares Short | 232 |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | March 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1499.12% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -113.52% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 137.86K CAD |
| Revenue Per Share (ttm) | 0.002 CAD |
| Quarterly Revenue Growth (yoy) | 86.09% |
| Gross Profit (ttm) | 43.93K CAD |
| EBITDA | -2053726 CAD |
| Net Income Avi to Common (ttm) | -2070594 CAD |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 133.9K CAD |
| Total Cash Per Share (mrq) | 0.002 CAD |
| Total Debt (mrq) | 1.68M CAD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.135 |
| Book Value Per Share (mrq) | -0.01 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1220092 CAD |
| Levered Free Cash Flow (ttm) | -533901 CAD |
Profile of Biomark Diagnostics Inc.
| Country | Canada |
| State | BC |
| City | Richmond |
| Address | 3851 Shell Road |
| ZIP | V6X 2W2 |
| Phone | 604 370 0779 |
| Website | https://www.biomarkdiagnostics.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
BioMark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It has a collaborative research agreement with the Icahn School of Medicine for clinical studies related to early lung cancer diagnosis. The company was incorporated in 2014 and is headquartered in Richmond, Canada. BioMark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.
Q&A For Biomark Diagnostics Inc. Stock
What is a current BUX.CN stock price?
Biomark Diagnostics Inc. BUX.CN stock price today per share is 0.24 CAD.
How to purchase Biomark Diagnostics Inc. stock?
You can buy BUX.CN shares on the Canadian Sec exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Biomark Diagnostics Inc.?
The stock symbol or ticker of Biomark Diagnostics Inc. is BUX.CN.
Which industry does the Biomark Diagnostics Inc. company belong to?
The Biomark Diagnostics Inc. industry is Diagnostics & Research.
How many shares does Biomark Diagnostics Inc. have in circulation?
The max supply of Biomark Diagnostics Inc. shares is 90.89M.
What is Biomark Diagnostics Inc. Price to Earnings Ratio (PE Ratio)?
Biomark Diagnostics Inc. PE Ratio is now.
What was Biomark Diagnostics Inc. earnings per share over the trailing 12 months (TTM)?
Biomark Diagnostics Inc. EPS is -0.02 CAD over the trailing 12 months.
Which sector does the Biomark Diagnostics Inc. company belong to?
The Biomark Diagnostics Inc. sector is Healthcare.